Helius Medical Technologies Inc - Class A chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.05
Dividend & YieldN/A$ (N/A)
Beta 1
Market capitalization 8.35M
Operating cash flow -15.63M
ESG Scores unknown

Company description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -1.09M -1.12M -809k 209k
Total Cashflows From Investing Activities -440k -769k -9k -56k
Net Borrowings
Total Cash From Financing Activities 40.03M 1.65M 9.64M 21.13M
Change To Operating Activities 720k -517k -432k -25k
Issuance Of Stock 43.19M 1.9M 9.18M 21.38M
Net Income -28.62M -9.78M -14.13M -18.13M
Change In Cash 20.02M -20.12M -2.13M 7.67M
Effect Of Exchange Rate 54k -9k -19k -8k
Total Cash From Operating Activities -19.62M -21M -11.74M -13.39M
Depreciation 59k 182k 482k 312k
Change To Account Receivables -259k -438k -4k 30k
Other Cashflows From Financing Activities -3.16M -247k 456k -251k
Change To Netincome 9.96M -9.08M 3.15M 4.3M
Capital Expenditures -440k -278k -63k -54k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 9.94M 8.06M 4.58M 5.99M
Income Before Tax -28.62M -9.78M -14.13M -18.13M
Net Income -28.62M -9.78M -14.13M -18.13M
Selling General Administrative 17.21M 16.42M 9.53M 11.88M
Gross Profit 478k 650k 273k 224k
Ebit -26.68M -23.9M -14.2M -17.84M
Operating Income -26.68M -23.9M -14.2M -17.84M
Interest Expense
Income Tax Expense
Total Revenue 478k 1.5M 661k 522k
Cost Of Revenue 846k 388k 298k
Total Other Income ExpenseNet -1.95M 14.12M 72k -290k
Net Income From Continuing Ops -28.62M -9.78M -14.13M -18.13M
Net Income Applicable To Common Shares -28.62M -9.78M -14.13M -18.13M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 17.97M 4.51M 2.68M 2.85M
Total Stockholder Equity 9.85M 5.83M 3.87M 11.26M
Other Current Liabilities 13.77M 435k 281k 148k
Total Assets 27.83M 10.35M 6.55M 14.1M
Common Stock 26k 1k 1k 4k
Other Current Assets 264k
Retained Earnings -94.99M -104.77M -118.9M -137.03M
Treasury Stock -591k -902k -1.1M -1.12M
Cash 25.58M 5.46M 3.33M 11.01M
Total Current Liabilities 17.97M 3.8M 2.42M 2.65M
Other Stockholder Equity -591k -902k -1.1M -1.12M
Property, Plant, and Equipment 554k 1.26M 576k 412k
Total Current Assets 26.96M 7.24M 4.68M 12.59M
Net Tangible Assets 9.85M 4.01M 2.58M 10.16M
Net Receivables 275k 574k 230k 251k
Accounts Payable 2.39M 1.68M 747k 1.07M


Insider Transactions

Here are the insider transactions of stock shares related to Helius Medical Technologies Inc - Class A:

Filer Name Transaction Text Ownership Date Filer Relation Shares
ANDREEFF DANE CStock Award(Grant) at price 0.46 per share.I2020-10-21Chief Executive Officer1.18M
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.46 per share.D2020-10-21Chief Operating Officer38.14k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.56 per share.D2020-07-31Chief Operating Officer4.95k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.52 per share.D2020-07-15Chief Operating Officer5.31k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.43 per share.D2020-06-30Chief Operating Officer6.43k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.49 per share.D2020-06-15Chief Operating Officer5.6k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.49 per share.D2020-05-29Chief Operating Officer5.56k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.50 per share.D2020-05-15Chief Operating Officer5.5k
ANDREEFF DANE CStock Award(Grant) at price 0.57 per share.I2020-05-13Director150k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.43 per share.D2020-04-30Chief Executive Officer9.32k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.43 per share.D2020-04-30Chief Operating Officer6.4k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.27 per share.D2020-04-15Chief Executive Officer14.81k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.27 per share.D2020-04-15Chief Operating Officer10.17k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.33 per share.D2020-03-31Chief Executive Officer12.12k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.33 per share.D2020-03-31Chief Operating Officer8.32k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.47 per share.D2020-03-13Chief Operating Officer5.84k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.47 per share.D2020-03-13Chief Executive Officer8.51k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.91 per share.D2020-02-28Chief Operating Officer3.02k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.91 per share.D2020-02-28Chief Executive Officer4.39k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.85 per share.D2020-02-14Chief Operating Officer3.23k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.85 per share.D2020-02-14Chief Executive Officer4.7k
LAVISCOUNT JOYCE NStock Award(Grant) at price 1.01 per share.D2020-01-31Chief Operating Officer2.72k
DESCHAMPS PHILIPPEStock Award(Grant) at price 1.01 per share.D2020-01-31Chief Executive Officer3.96k
LAVISCOUNT JOYCE NStock Award(Grant) at price 1.04 per share.D2020-01-15Chief Operating Officer2.64k
DESCHAMPS PHILIPPEStock Award(Grant) at price 1.04 per share.D2020-01-15Chief Executive Officer3.84k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.97 per share.D2019-12-31Chief Operating Officer2.83k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.97 per share.D2019-12-31Chief Executive Officer4.12k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.44 per share.D2019-12-13Chief Operating Officer6.24k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.44 per share.D2019-12-13Chief Executive Officer9.09k
ANDREEFF DANE CStock Award(Grant) at price 0.35 per share.I2019-11-27Director571.43k
DESCHAMPS PHILIPPEConversion of Exercise of derivative security at price 5.60 per share.D2019-04-05Chief Executive Officer5.02k
LAVISCOUNT JOYCE NStock Award(Grant) at price 0.00 per share.D2016-04-18Chief Operating Officer50.22k
DESCHAMPS PHILIPPEStock Award(Grant) at price 0.00 per share.D2016-04-18Chief Executive Officer50.19k
BAPTY BRIANStock Award(Grant) at price 0.00 per share.D2016-04-18Officer50k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Helius Medical Technologies Inc - Class A. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Helius Medical Technologies Inc - Class A

Here is the result of two systematic investment strategies applied to Helius Medical Technologies Inc - Class A. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Helius Medical Technologies Inc - Class A

The following chart shows the equity curve of the two systematic investment strategies applied to Helius Medical Technologies Inc - Class A:

Helius Medical Technologies Inc - Class A automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -41.55% on the backtest period.

Performance at glance

Performance

-41.55 %

Latent gain

-721.17 $

Invested capital

1735.51 $

Annualized return

-10.13 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Helius Medical Technologies Inc - Class A

This is the result of two momentum investment strategies applied to Helius Medical Technologies Inc - Class A. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Helius Medical Technologies Inc - Class A

The following chart shows all the entries opened by the momentum investment system on Helius Medical Technologies Inc - Class A:

Helius Medical Technologies Inc - Class A momentum entries
  • The first momentum investment strategy would give -48.17% of return on Helius Medical Technologies Inc - Class A. That represents -2839.42$ of latent gain with 5894.81$ of employed capital.
  • The second momentum investment strategy would give -46.1% of return on Helius Medical Technologies Inc - Class A. That represents -1714.2$ of latent gain with 3718.14$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-48.17 %

Latent gain

-2839.42 $

Invested capital

5894.81 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-46.1 %

Latent gain

-1714.2 $

Invested capital

3718.14 $

Annualized return

-12.73 %

Momentum equity curve on Helius Medical Technologies Inc - Class A

The following chart shows the equity curve of the two momentum strategies applied to Helius Medical Technologies Inc - Class A:

Helius Medical Technologies Inc - Class A momentum equity

Note: the dividends potentially given by Helius Medical Technologies Inc - Class A are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Helius Medical Technologies Inc - Class A

The following chart shows the employed capital evolution of the two momentum strategies on Helius Medical Technologies Inc - Class A since the beginning:

Helius Medical Technologies Inc - Class A

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Helius Medical Technologies Inc - Class A

Buy the dip entry openings on Helius Medical Technologies Inc - Class A

Helius Medical Technologies Inc - Class A

The performance achieved by the robo-advisor on Helius Medical Technologies Inc - Class A is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Helius Medical Technologies Inc - Class A stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Helius Medical Technologies Inc - Class A, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Helius Medical Technologies Inc - Class A

The following chart shows the result of the investment strategy applied to Helius Medical Technologies Inc - Class A:

Helius Medical Technologies Inc - Class A

Note: the dividends potentially given by Helius Medical Technologies Inc - Class A are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Helius Medical Technologies Inc - Class A

The following chart shows the employed capital evolution since the beginning of the investment strategy on Helius Medical Technologies Inc - Class A:

Helius Medical Technologies Inc - Class A

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Helius Medical Technologies Inc - Class A

In this section, I will compare the three previous investment strategies applied to Helius Medical Technologies Inc - Class A.

Equity curve comparison on Helius Medical Technologies Inc - Class A

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Helius Medical Technologies Inc - Class A investment strategy comparison

Employed capital comparison on Helius Medical Technologies Inc - Class A

Helius Medical Technologies Inc - Class A investment comparison

Performance comparison on Helius Medical Technologies Inc - Class A

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -41.55% -721.17$ 1735.51$ -10.13%
Momentum 1 quarter -48.17% -2839.42$ 5894.81$ -12.48%
Momentum 2 quarters -46.1% -1714.2$ 3718.14$ -12.73%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-10.13 %

Momentum 1Q

-12.73 %

Momentum 2Q

-12.73 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Helius Medical Technologies Inc - Class A:

Positive correlations

Most correlated stocks this year

  • Helius Medical Technologies Inc - Class A

  • Most correlated stocks last 3 months

  • Corvus Pharmaceuticals Inc
  • HONGGUANG LIGHT
  • Helius Medical Technologies Inc - Class A
  • BENETEAU

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Helius Medical Technologies Inc - Class A and the other stocks. There may be false positives or some missing correlated stocks. If the price of Helius Medical Technologies Inc - Class A does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Helius Medical Technologies Inc - Class A
    Country United States
    City Newtown
    Address 642 Newtown Yardley Road
    Phone 215 944 6100
    Website heliusmedical.com
    FullTime employees 19
    Industry Medical Devices
    Sector Healthcare
    Exchange XNAS
    Ticker HSDT
    Market www.nasdaq.com

    Helius Medical Technologies Inc - Class A ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown